Derrell D. Porter's most recent trade in Acumen Pharmaceuticals Inc was a trade of 13,040 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharma Inc | Derrell D. Porter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 13,040 | 0 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 15 Jun 2026 | 13,040 | 35,500 | - | 2.3 | 30,318 | Common Stock |
| Acumen Pharma Inc | Derrell D. Porter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 15 Jun 2026 | 13,040 | 48,540 | - | 1.1 | 13,953 | Common Stock |
| Acumen Pharma Inc | Derrell D. Porter | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 15 Jun 2026 | 12,800 | 35,500 | - | 2.3 | 29,773 | Common Stock |
| Acumen Pharma Inc | Derrell D. Porter | Director | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 15 Jun 2026 | 6,460 | 48,300 | - | 2.3 | 15,149 | Common Stock |
| Acumen Pharma Inc | Derrell D. Porter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 15 Jun 2026 | 6,460 | 54,760 | - | 1.1 | 6,912 | Common Stock |
| Acumen Pharma Inc | Derrell D. Porter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 6,460 | 13,040 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 48,300 | - | 0 | Common Stock | |
| Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 10,539 | 10,539 | - | - | Director Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 12,800 | 12,800 | - | 0 | Common Stock | |
| Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 201,857 | 201,857 | - | - | Director Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) | |
| Passage Bio Inc | Derrell Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) |